AWAKN Life Sciences Inc.

Private Company

Company Logo

Company Overview

AWAKN is a UK and European focused company that is dedicated to integrating psychedelics into mental healthcare. The company work sacross three business lines: Clinical research, therapeutic clinics and practitioner training.

Clinical Trials

On-demand research and clinical trials – study design, enrollment, execution – for the medicalisation of psychedelic assisted therapy. Advancing mental health through pre-clinical, Phase I-III, regulatory submissions and IP creation.

Therapeutic Clinics

A revolutionary shift in the treatment approach for mental health disorders, under the leadership of psychiatric specialist, researcher, author and clinic founder, Dr. Ben Sessa.

Practitioner Training

Innovative psychedelic training for Psychiatrists and Psychologists to pivot into the future of mental health disorder treatments.

Management Team

Anthony Tennyson
Chief Executive Officer

Dr. Ben Sessa
Chief Medical Officer

Jonathan Held
Chief Financial Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile